---
title: "Paychex: Competitors"
description: "Paychex compared with companies that share its SEC industry classification: revenue, growth and margins from SEC filings, and how the peer group is chosen."
canonical: https://www.getswoopr.com/stocks/companies/paychex/competitors/
source: "Swoopr Investment: https://www.getswoopr.com"
---

# Paychex: Competitors & Industry Structure

## Direct Answer

SEC EDGAR classifies Paychex under SIC major group 87. Among Swoopr's S&P 500 Equal Weight companies, 40 others share that classification; by latest reported revenue, Paychex ranks 4 of 41. A filing classification is a starting point: a company's real competitors depend on its segments, which its 10-K describes.

## How Does Paychex Compare With Its Peers?

| Company | Revenue (latest FY) | Revenue growth | Operating margin | Net margin |
| --- | --- | --- | --- | --- |
| [IQVIA (IQV)](https://www.getswoopr.com/stocks/companies/iqvia/) | $16.3 billion FY2025 | 5.9% | 13.4% | 8.3% |
| [AECOM (ACM)](https://www.getswoopr.com/stocks/companies/aecom/) | $16.1 billion FY2025 | 0.2% | 6.4% | 3.5% |
| [Booz Allen Hamilton Holding Corporation (BAH)](https://www.getswoopr.com/stocks/companies/booz-allen-hamilton-holding-corporation/) | $11.2 billion FY2026 | -6.4% | 9.2% | 7.6% |
| **Paychex (PAYX)** | $6.5 billion FY2026 | 16.9% | 38.6% | 27.0% |
| [Gartner (IT)](https://www.getswoopr.com/stocks/companies/gartner/) | $6.5 billion FY2025 | 3.7% | 15.8% | 11.2% |
| [Tetra Tech Inc. (TTEK)](https://www.getswoopr.com/stocks/companies/tetra-tech-inc/) | $5.4 billion FY2025 | 4.7% | 7.5% | 4.6% |
| [Incyte (INCY)](https://www.getswoopr.com/stocks/companies/incyte/) | $5.1 billion FY2025 | 21.2% | 29.5% | 25.0% |
| [Charles River Laboratories (CRL)](https://www.getswoopr.com/stocks/companies/charles-river-laboratories/) | $4.0 billion FY2025 | -0.9% | 0.6% | -3.6% |
| [FTI Consulting Inc. (FCN)](https://www.getswoopr.com/stocks/companies/fti-consulting-inc/) | $3.8 billion FY2025 | 2.4% | 10.3% | 7.1% |
| [UL Solutions Inc. (ULS)](https://www.getswoopr.com/stocks/companies/ul-solutions-inc/) | $3.1 billion FY2025 | 6.4% | 17.1% | 10.6% |
| [Medpace Holdings Inc. (MEDP)](https://www.getswoopr.com/stocks/companies/medpace-holdings-inc/) | $2.5 billion FY2025 | 20.0% | 21.1% | 17.8% |
| [Evolent Health Inc (EVH)](https://www.getswoopr.com/stocks/companies/evolent-health-inc/) | $1.9 billion FY2025 | -26.6% | -21.9% | -30.9% |
| [ICF International Inc. (ICFI)](https://www.getswoopr.com/stocks/companies/icf-international-inc/) | $1.9 billion FY2025 | -7.3% | 7.8% | 4.9% |
| [Huron Consulting Group Inc. (HURN)](https://www.getswoopr.com/stocks/companies/huron-consulting-group-inc/) | $1.7 billion FY2025 | 11.7% | 10.5% | 6.2% |
| [Onterris Inc. (ONT)](https://www.getswoopr.com/stocks/companies/onterris-inc/) | $831 million FY2025 | 19.3% | 1.4% | -0.1% |
| [Mistras Group Inc (MG)](https://www.getswoopr.com/stocks/companies/mistras-group-inc/) | $724 million FY2025 | -0.8% | 5.6% | 2.3% |
| [The RMR Group Inc. (RMR)](https://www.getswoopr.com/stocks/companies/the-rmr-group-inc/) | $700 million FY2025 | -22.0% | 6.0% | 2.5% |
| [Willdan Group Inc. (WLDN)](https://www.getswoopr.com/stocks/companies/willdan-group-inc/) | $682 million FY2025 | 20.5% | 6.5% | 7.7% |
| [Exponent Inc. (EXPO)](https://www.getswoopr.com/stocks/companies/exponent-inc/) | $582 million FY2025 | 4.2% | 20.6% | 18.2% |
| [Bowman Consulting Group Ltd. (BWMN)](https://www.getswoopr.com/stocks/companies/bowman-consulting-group-ltd/) | $490 million FY2025 | 14.9% | 4.0% | 2.6% |
| [Forrester Research Inc. (FORR)](https://www.getswoopr.com/stocks/companies/forrester-research-inc/) | $397 million FY2025 | -8.2% | -28.5% | -30.1% |
| [Hackett Group Inc (The). (HCKT)](https://www.getswoopr.com/stocks/companies/hackett-group-inc-the/) | $306 million FY2025 | -2.6% | 7.7% | 4.2% |
| [Franklin Covey Company (FC)](https://www.getswoopr.com/stocks/companies/franklin-covey-company/) | $267 million FY2025 | -7.0% | 2.1% | 1.1% |
| [TSS Inc. (TSSI)](https://www.getswoopr.com/stocks/companies/tss-inc/) | $246 million FY2025 | 65.9% | 2.6% | 6.2% |
| [Information Services Group Inc. (III)](https://www.getswoopr.com/stocks/companies/information-services-group-inc/) | $245 million FY2025 | -1.2% | 7.3% | 3.8% |
| [Mastech Digital Inc (MHH)](https://www.getswoopr.com/stocks/companies/mastech-digital-inc/) | $191 million FY2025 | -3.8% | 0.0% | 0.0% |
| [Public Policy Holding Company Inc. (PPHC)](https://www.getswoopr.com/stocks/companies/public-policy-holding-company-inc/) | $187 million FY2025 | 24.7% | -18.2% | -20.9% |
| [NRC Health (NRC)](https://www.getswoopr.com/stocks/companies/nrc-health/) | $137 million FY2025 | -4.0% | 16.4% | 8.4% |
| [Aeries Technology Inc. (AERT)](https://www.getswoopr.com/stocks/companies/aeries-technology-inc/) | $70 million FY2026 | -0.3% | 6.5% | 4.0% |
| [MaxCyte Inc. (MXCT)](https://www.getswoopr.com/stocks/companies/maxcyte-inc/) | $33 million FY2025 | -14.5% | -157.1% | -135.1% |
| [CISO Global Inc. (CISO)](https://www.getswoopr.com/stocks/companies/ciso-global-inc/) | $27 million FY2025 | -13.5% | -33.0% | -30.3% |
| [ACCESS Newswire Inc. (ACCS)](https://www.getswoopr.com/stocks/companies/access-newswire-inc/) | $23 million FY2025 | -1.9% | -8.3% | 19.0% |
| [OmniAb Inc. (OABI)](https://www.getswoopr.com/stocks/companies/omniab-inc/) | $19 million FY2025 | -29.3% | -369.5% | -347.0% |
| [Acorn Energy Inc. (ACFN)](https://www.getswoopr.com/stocks/companies/acorn-energy-inc/) | $11 million FY2025 | 4.5% | 17.3% | 21.9% |
| [RTB Digital Inc. (RTB)](https://www.getswoopr.com/stocks/companies/rtb-digital-inc/) | $11 million FY2025 | -38.7% | -118.1% | -157.5% |
| [bioAffinity Technologies Inc. (BIAF)](https://www.getswoopr.com/stocks/companies/bioaffinity-technologies-inc/) | $6 million FY2025 | -34.2% | -171.6% | -242.0% |
| [T3 Defense Inc. (DFNS)](https://www.getswoopr.com/stocks/companies/t3-defense-inc/) | $6 million FY2024 | -72.2% | -120.1% | -144.1% |
| [Absci Corporation (ABSI)](https://www.getswoopr.com/stocks/companies/absci-corporation/) | $3 million FY2025 | -38.2% | -4297.0% | -4113.7% |
| [20/20 Biolabs Inc. (AIDX)](https://www.getswoopr.com/stocks/companies/20-20-biolabs-inc/) | $2 million FY2025 | 16.7% | -162.9% | -182.8% |
| [iSpecimen Inc. (ISPC)](https://www.getswoopr.com/stocks/companies/ispecimen-inc/) | $2 million FY2025 | -79.2% | -465.4% | -543.7% |
| [ATIF Holdings Limited (AUC)](https://www.getswoopr.com/stocks/companies/atif-holdings-limited/) | $620,000 FY2024 | -74.7% | -316.1% | -296.9% |

Revenue growth compares each company's latest fiscal year with the one before. Fiscal years do not always end on the same date, so treat close comparisons with care.

![Bar chart of operating margin for Paychex and 7 peers: IQVIA (IQV) 13.4%, AECOM (ACM) 6.4%, Booz Allen Hamilton Holding Corporation (BAH) 9.2%, Paychex (PAYX) 38.6%, Gartner (IT) 15.8%, Tetra Tech Inc. (TTEK) 7.5%, Incyte (INCY) 29.5%, Charles River Laboratories (CRL) 0.6%.](https://www.getswoopr.com/images/charts/paychex-competitors-peer-margins.webp)
*Operating margin of Paychex against companies sharing its SEC industry classification, from the table above. Select the chart to open it full size.*

## Where These Numbers Come From

Every figure on this page is a value Paychex reported in its own SEC filings, read from the SEC's XBRL data (accession 0001193125-26-307785 for fiscal year 2026). Ratios are computed from those reported values. Figures were retrieved on October 7, 2026; a later amendment or a new annual report can change them, and the filing itself always takes precedence over this summary.

Each fiscal year is labeled by the calendar year in which it ended, so a company that names the same period differently in its own filings (many retailers whose year ends in January) may use another label. A year is left out of the table when the SEC data set holds no value for it. A figure shown as "Not reported" means the company did not file a value under the standard tag Swoopr reads, not that the amount was zero. This page is educational and describes reported history only; it is not a forecast or a recommendation.

## Frequently Asked Questions

### Who are Paychex's competitors?

Companies sharing Paychex's SEC classification (SIC major group 87) include IQVIA (IQV), AECOM (ACM), Booz Allen Hamilton Holding Corporation (BAH), Gartner (IT), Tetra Tech Inc. (TTEK). Its 10-K names the competitors it considers most relevant.

### How does Paychex compare with its peers on margins?

Paychex's fiscal 2026 operating margin was 38.6%, against a peer median of 4.8%.

### How are these peers chosen?

By the SEC Standard Industrial Classification code each company files under, within Swoopr's S&P 500 Equal Weight company set, falling back to the two-digit major group when fewer than two companies share the exact code. Classification codes are broad, so read the peer list as a screen, not a verdict.

## References

- [SEC EDGAR: PAYCHEX INC Form 10-K filed July 17, 2026](https://www.sec.gov/Archives/edgar/data/723531/000119312526307785/payx-20260531.htm)
- [SEC EDGAR: PAYCHEX INC annual and quarterly filings](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=723531&type=10-K)
- [SEC: EDGAR application programming interfaces (XBRL frames and submissions data)](https://www.sec.gov/search-filings/edgar-application-programming-interfaces)

## Related Pages

- [Paychex company dossier](https://www.getswoopr.com/stocks/companies/paychex/)
- [Paychex financial metrics](https://www.getswoopr.com/stocks/companies/paychex/metrics/)
- [Paychex financial risk indicators](https://www.getswoopr.com/stocks/companies/paychex/risks/)
- [Paychex peer comparison](https://www.getswoopr.com/stocks/companies/paychex/competitors/)
- [Paychex business model and revenue mix](https://www.getswoopr.com/stocks/companies/paychex/business-model/)
- [Fundamental analysis guides](https://www.getswoopr.com/learn/fundamental-analysis/)

**[Swoopr Editorial Team](https://www.getswoopr.com/authors/swoopr-editorial-team/)**

Swoopr's editorial team produces independent investment education content reviewed for accuracy and clarity. We do not provide personalized financial advice. See our [editorial policy](https://www.getswoopr.com/legal/editorial-policy/) and [corrections policy](https://www.getswoopr.com/legal/corrections-policy/).
